 HEIDELBERG, Germany, Aug. 04, 2022 GLOBE NEWSWIRE -- Affimed N.V. Nasdaq: AFMD Affimed, or the Company, a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release second quarter 2022 results and corporate update on Thursday, August 11, 2022. The Company will host a conference call at 8:30 a.m. Eastern Daylight Time. 